Compare NTRB & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRB | DLHC |
|---|---|---|
| Founded | 2016 | 1969 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.6M | 61.2M |
| IPO Year | 2019 | 2012 |
| Metric | NTRB | DLHC |
|---|---|---|
| Price | $6.59 | $4.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 120.0K | 12.9K |
| Earning Date | 09-04-2026 | 07-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,036,651.00 | ★ $41,923,000.00 |
| Revenue This Year | $4,584.65 | N/A |
| Revenue Next Year | $89.09 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.57 |
| 52 Week Low | $2.80 | $3.38 |
| 52 Week High | $9.19 | $8.09 |
| Indicator | NTRB | DLHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 50.84 |
| Support Level | $6.56 | $3.61 |
| Resistance Level | $9.19 | $4.23 |
| Average True Range (ATR) | 0.89 | 0.19 |
| MACD | -0.29 | 0.07 |
| Stochastic Oscillator | 25.10 | 75.00 |
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.